ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc.

·1 min read

NEW YORK, June 16, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kindred Biosciences, Inc. (NASDAQ: KIN) and its board of directors concerning the proposed acquisition of the company by Elanco Animal Health Incorporated (NYSE: ELAN). Stockholders will receive $9.25 for each share of Kindred Biosciences stock that they hold. The transaction is valued at approximately $440 million and is expected to close in the third quarter of 2021.

If you are a stockholder of Kindred Biosciences, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit

Attorney Advertising. Prior results do not guarantee a similar outcome.


View original content:


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting